Skip to main content
Erschienen in: Clinical Drug Investigation 3/2010

01.03.2010 | Original Research Article

Hospitalization for Severe Bacterial Infections in Children after Exposure to NSAIDs

A Prospective Adverse Drug Reaction Reporting Study

verfasst von: Sandrine Leroy, Elisabeth Marc, Françoise Bavoux, Jean-Marc Tréluyer, Dominique Gendrel, Gérard Bréart, Gérard Pons, Professor Martin Chalumeau

Erschienen in: Clinical Drug Investigation | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background: NSAIDs are widely used to treat fever and pain in children, but their possible role in the progression of some bacterial infections is controversial.
Objective: This study was performed to analyse reported cases of severe bacterial infection associated with NSAID exposure in children admitted for this reason to a general paediatric department.
Methods: This study was based on the reporting system of hospital admissions for severe bacterial infections in children after NSAID exposure, and followed the recommendations of the European Guidelines of Pharmacovigilance for medicines used in a paediatric population. Data were prospectively collected and reported by active daily surveillance in the department from November 2002 to November 2005.
Results: Thirty-two cases of severe bacterial infections (cellulitis, soft tissue abscesses, parapneumonic empyema, necrotizing pneumonia, adenophlegmon [fever and a tender, warm and easily compressible neck mass] and lateral or retropharyngeal abscesses) were identified in children who had received NSAIDs, principally ibuprofen, in an exposure window of 15 days before the beginning of the signs of infection. Staphylococcus aureus, group A streptococci and Streptococcus pneumoniae were identified. Seven (22%) children required surgical treatment, and four (13%) were hospitalized in an intensive care unit. The frequency of hospitalization for severe bacterial infection as a possible adverse effect of NSAID use was 0.6% (95% CI 0.4, 0.9) of all admissions during the study period.
Conclusions: The frequency of severe bacterial infections after exposure to NSAIDs was elevated (one case per month) in the department studied. Further work is necessary to confirm these findings, given the potential for recruitment and protopathic biases in our study.
Literatur
1.
Zurück zum Zitat Autret-Leca E. A general overview of the use of ibuprofen in paediatrics. Int J Clin Pract Suppl 2003; 135: 9–12PubMed Autret-Leca E. A general overview of the use of ibuprofen in paediatrics. Int J Clin Pract Suppl 2003; 135: 9–12PubMed
2.
Zurück zum Zitat Perrott DA, Piira T, Goodenough B, et al. Efficacy and safety of acetaminophen vs ibuprofen for treating children’s pain or fever: a meta-analysis. Arch Pediatr Adolesc Med 2004; 158: 521–6PubMedCrossRef Perrott DA, Piira T, Goodenough B, et al. Efficacy and safety of acetaminophen vs ibuprofen for treating children’s pain or fever: a meta-analysis. Arch Pediatr Adolesc Med 2004; 158: 521–6PubMedCrossRef
3.
Zurück zum Zitat Goldman RD, Ko K, Linett LJ, et al. Antipyretic efficacy and safety of ibuprofen and acetaminophen in children. Ann Pharmacother 2004; 38: 146–50PubMedCrossRef Goldman RD, Ko K, Linett LJ, et al. Antipyretic efficacy and safety of ibuprofen and acetaminophen in children. Ann Pharmacother 2004; 38: 146–50PubMedCrossRef
4.
Zurück zum Zitat Leroy S, Mosca A, Landre-Peigne C, et al. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr 2007; 14: 477–84PubMedCrossRef Leroy S, Mosca A, Landre-Peigne C, et al. Ibuprofen in childhood: evidence-based review of efficacy and safety. Arch Pediatr 2007; 14: 477–84PubMedCrossRef
5.
Zurück zum Zitat Neutel CI, Pless RP. Ibuprofen use in children: a benefit or a risk? Ann Epidemiol 1997; 7: 437–9PubMedCrossRef Neutel CI, Pless RP. Ibuprofen use in children: a benefit or a risk? Ann Epidemiol 1997; 7: 437–9PubMedCrossRef
6.
Zurück zum Zitat Ulinski T, Guigonis V, Dunan O, et al. Acute renal failure after treatment with non-steroidal anti-inflammatory drugs. Eur J Pediatr 2004; 163: 148–50PubMedCrossRef Ulinski T, Guigonis V, Dunan O, et al. Acute renal failure after treatment with non-steroidal anti-inflammatory drugs. Eur J Pediatr 2004; 163: 148–50PubMedCrossRef
7.
Zurück zum Zitat Kahn LH, Styrt BA. Necrotizing soft tissue infections reported with nonsteroidal antiinflammatory drugs. Ann Pharmacother 1997; 31: 1034–9PubMed Kahn LH, Styrt BA. Necrotizing soft tissue infections reported with nonsteroidal antiinflammatory drugs. Ann Pharmacother 1997; 31: 1034–9PubMed
8.
Zurück zum Zitat Zerr DM, Alexander ER, Duchin JS, et al. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999; 103: 783–90PubMedCrossRef Zerr DM, Alexander ER, Duchin JS, et al. A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999; 103: 783–90PubMedCrossRef
9.
Zurück zum Zitat Hamilton SM, Bayer CR, Stevens DL, et al. Muscle injury, vimentin expression, and nonsteroidal antiinflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J Infect Dis 2008; 198: 1692–8PubMedCrossRef Hamilton SM, Bayer CR, Stevens DL, et al. Muscle injury, vimentin expression, and nonsteroidal antiinflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J Infect Dis 2008; 198: 1692–8PubMedCrossRef
10.
Zurück zum Zitat Aronoff DM, Mulla ZD. Nonsteroidal antiinflammatory drugs and group A streptococcal infection [letter]. Emerg Infect Dis 2006; 12: 1291PubMedCrossRef Aronoff DM, Mulla ZD. Nonsteroidal antiinflammatory drugs and group A streptococcal infection [letter]. Emerg Infect Dis 2006; 12: 1291PubMedCrossRef
11.
Zurück zum Zitat Factor SH, Levine OS, Harrison LH, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005; 11: 1062–6PubMedCrossRef Factor SH, Levine OS, Harrison LH, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005; 11: 1062–6PubMedCrossRef
12.
Zurück zum Zitat Lesko SM, O’Brien KL, Schwartz B, et al. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 2001; 107: 1108–15PubMedCrossRef Lesko SM, O’Brien KL, Schwartz B, et al. Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 2001; 107: 1108–15PubMedCrossRef
13.
Zurück zum Zitat Brogan TV, Nizet V, Waldhausen JH, et al. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995; 14: 588–94PubMedCrossRef Brogan TV, Nizet V, Waldhausen JH, et al. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995; 14: 588–94PubMedCrossRef
14.
Zurück zum Zitat Dubos F, Hue V, Grandbastien B, et al. Bacterial skin infections in children hospitalized with varicella: a possible negative impact of non-steroidal anti-inflammatory drugs? Acta Derm Venereol 2008; 88: 26–30PubMedCrossRef Dubos F, Hue V, Grandbastien B, et al. Bacterial skin infections in children hospitalized with varicella: a possible negative impact of non-steroidal anti-inflammatory drugs? Acta Derm Venereol 2008; 88: 26–30PubMedCrossRef
16.
Zurück zum Zitat Bauvin I, Lacoste A, Bonamy C. Abcès rétro et parapharyngés de l’enfant: à propos d’une série de 31 cas [abstract]. Arch Pediatr 2006; 13: 874 Bauvin I, Lacoste A, Bonamy C. Abcès rétro et parapharyngés de l’enfant: à propos d’une série de 31 cas [abstract]. Arch Pediatr 2006; 13: 874
17.
Zurück zum Zitat Revol P, Gleizal A, Kraft T, et al. Brain abscess and diffuse cervico-facial cellulitis: complication after mandibular third molar extraction. Rev Stomatol Chir Maxillofac 2003; 104: 285–9PubMed Revol P, Gleizal A, Kraft T, et al. Brain abscess and diffuse cervico-facial cellulitis: complication after mandibular third molar extraction. Rev Stomatol Chir Maxillofac 2003; 104: 285–9PubMed
18.
Zurück zum Zitat Audebert S, Vic P, Feuvrier Y, et al. Radiological quiz of the month. Arch Pediatr 2004; 11: 1472, 95-7PubMedCrossRef Audebert S, Vic P, Feuvrier Y, et al. Radiological quiz of the month. Arch Pediatr 2004; 11: 1472, 95-7PubMedCrossRef
19.
Zurück zum Zitat Byington CL, Spencer LY, Johnson TA, et al. An epidemio-logical investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002; 34: 434–40PubMedCrossRef Byington CL, Spencer LY, Johnson TA, et al. An epidemio-logical investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002; 34: 434–40PubMedCrossRef
20.
Zurück zum Zitat Lamagni TL, Neal S, Keshishian C, et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003–2004. Emerg Infect Dis 2008; 14: 202–9PubMedCrossRef Lamagni TL, Neal S, Keshishian C, et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003–2004. Emerg Infect Dis 2008; 14: 202–9PubMedCrossRef
21.
Zurück zum Zitat Horwitz RI, Feinstein AR. The problem of ‘protopathic bias’ in case-control studies. Am J Med 1980; 68: 255–8PubMedCrossRef Horwitz RI, Feinstein AR. The problem of ‘protopathic bias’ in case-control studies. Am J Med 1980; 68: 255–8PubMedCrossRef
22.
Zurück zum Zitat Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA 1995; 273: 929–33PubMedCrossRef Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen: a practitioner-based randomized clinical trial. JAMA 1995; 273: 929–33PubMedCrossRef
23.
Zurück zum Zitat Mitchell AA, Lesko SM. When a randomised controlled trial is needed to assess drug safety: the case of paediatric ibuprofen. Drug Saf 1995; 13: 15–24PubMedCrossRef Mitchell AA, Lesko SM. When a randomised controlled trial is needed to assess drug safety: the case of paediatric ibuprofen. Drug Saf 1995; 13: 15–24PubMedCrossRef
24.
Zurück zum Zitat Lesko SM, Mitchell AA. Renal function after short-term ibuprofen use in infants and children. Pediatrics 1997; 100: 954–7PubMedCrossRef Lesko SM, Mitchell AA. Renal function after short-term ibuprofen use in infants and children. Pediatrics 1997; 100: 954–7PubMedCrossRef
25.
Zurück zum Zitat Committee for Medical Products for Human Use. Guideline on conduct of pharmacovigilance for medicines used by the paediatric population. European Medicines Agency 2005 [online]. Available from URL: http://www.emea.europa.eu [Accessed 2009 Nov 10] Committee for Medical Products for Human Use. Guideline on conduct of pharmacovigilance for medicines used by the paediatric population. European Medicines Agency 2005 [online]. Available from URL: http://​www.​emea.​europa.​eu [Accessed 2009 Nov 10]
26.
Zurück zum Zitat Choo PW, Donahue JG, Platt R. Ibuprofen and skin and soft tissue superinfections in children with varicella. Ann Epidemiol 1997; 7: 440–5PubMedCrossRef Choo PW, Donahue JG, Platt R. Ibuprofen and skin and soft tissue superinfections in children with varicella. Ann Epidemiol 1997; 7: 440–5PubMedCrossRef
27.
Zurück zum Zitat Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef
28.
Zurück zum Zitat Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995; 21: 977–80PubMedCrossRef Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995; 21: 977–80PubMedCrossRef
29.
Zurück zum Zitat Bensouda L, Michaud L, Jonville-Bera APJ, et al. Is the risk of upper gastrointestinal bleeding increased with NSAID used as analgesic, in children: a case crossover study. Drug Saf 2004; 27: 919–20 Bensouda L, Michaud L, Jonville-Bera APJ, et al. Is the risk of upper gastrointestinal bleeding increased with NSAID used as analgesic, in children: a case crossover study. Drug Saf 2004; 27: 919–20
Metadaten
Titel
Hospitalization for Severe Bacterial Infections in Children after Exposure to NSAIDs
A Prospective Adverse Drug Reaction Reporting Study
verfasst von
Sandrine Leroy
Elisabeth Marc
Françoise Bavoux
Jean-Marc Tréluyer
Dominique Gendrel
Gérard Bréart
Gérard Pons
Professor Martin Chalumeau
Publikationsdatum
01.03.2010
Verlag
Springer International Publishing
Erschienen in
Clinical Drug Investigation / Ausgabe 3/2010
Print ISSN: 1173-2563
Elektronische ISSN: 1179-1918
DOI
https://doi.org/10.2165/11532890-000000000-00000

Weitere Artikel der Ausgabe 3/2010

Clinical Drug Investigation 3/2010 Zur Ausgabe